Ascendis Pharma A/S (ASND) insider trading.
In Q3 2026, insiders at Ascendis Pharma A/S reported 5 non-derivative transactions on 4 Forms 3, 4 and 5: 2 open-market purchases worth $493K and 2 sales worth $873K.
- Transactions
- 5
- Purchases (P)
- 2
- Sales (S)
- 2
- Net shares, P minus S
- -1,236
- Insiders
- 3
- Last filed
- 2026-09-09
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Bodenhoff Mads | Officer · SVP & PAO | 2 | 0 | 1 |
| Bienaime Jean Jacques | Director | 2 | 2 | 0 |
| Holtug Lars | Director | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-08 | Bodenhoff Mads | M (A) | 3,000 | $110 | 3,000 | Form 4 |
| 2026-09-08 | Bodenhoff Mads | S (D) | 3,000 | $270.19 | 0 | Form 4 |
| 2026-09-02 | Holtug Lars | S (D) | 236 | $264.13 | 4,000 | Form 4 |
| 2026-08-14 | Bienaime Jean Jacques | P (A) | 1,100 | $245.85 | 2,000 | Form 4 |
| 2026-08-14 | Bienaime Jean Jacques | P (A) | 900 | $246.91 | 2,900 | Form 4 |
Transaction codes in this quarter
Get ASND insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1612042&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ASND company page · Ascendis Pharma A/S on SEC.gov
Questions
Are insiders buying or selling Ascendis Pharma A/S (ASND)?
In Q3 2026, insiders at Ascendis Pharma A/S reported 5 non-derivative transactions on 4 Forms 3, 4 and 5: 2 open-market purchases worth $493K and 2 sales worth $873K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Ascendis Pharma A/S insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/asnd.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.